Anticoagulation prior to cardioversion of atrial fibrillation (AF)
Cardioversion of atrial fibrillation (AF) carries a moderate risk of thromboembolism in patients who have been in AF for more than 2 days.
In people with atrial fibrillation in whom the duration of the arrhythmia is greater than 48 hours or uncertain and considered for long-term rhythm control, delay cardioversion until they have been maintained on therapeutic anticoagulation for a minimum of 3 weeks. During this period offer rate control as appropriate
Reference:
Related pages
Create an account to add page annotations
Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page